Daniel Barber

Daniel Barber

Directeur Général chez AQUESTIVE THERAPEUTICS, INC.

Fortune : 4 M $ au 31/05/2024

48 ans
Consumer Services
Health Technology
Health Services

Provenance du réseau au premier degré de Daniel Barber

EntitéType d'entitéIndustrie
Public Company Pharmaceuticals: Major 31

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Daniel Barber via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
SOLIGENIX, INC. Pharmaceuticals: Major

John McCracken

Corporate Officer/Principal

ABEONA THERAPEUTICS INC. Pharmaceuticals: Major

Eric J. Dadey

Corporate Officer/Principal

VIVUS, INC. Pharmaceuticals: Major

Timothy Morris

Director of Finance/CFO

DELCATH SYSTEMS, INC. Medical Specialties

Marco Taglietti

Director/Board Member

FEMASYS INC. Electronic Equipment/Instruments

Keith Kendall

Director/Board Member

Miscellaneous Commercial Services

John Cochran

Corporate Officer/Principal

SCYNEXIS, INC. Pharmaceuticals: Major

Marco Taglietti

Chief Executive Officer

Miscellaneous Commercial Services

Carl Kraus

Chief Tech/Sci/R&D Officer

Texas Christian University College/University

John Cochran

Undergraduate Degree

North Carolina State University College/University

Douglas Bratton

Undergraduate Degree

Pace University College/University

A. Toth

Keith Kendall

Masters Business Admin

Masters Business Admin

St. John's University College/University

Santo Costa

Keith Kendall

Graduate Degree

Undergraduate Degree

University of Western Kentucky College/University

Eric J. Dadey

Graduate Degree

University of Illinois College/University

Eric J. Dadey

Corporate Officer/Principal

University of Kentucky College/University

Eric J. Dadey

Doctorate Degree

NEPHROGENEX INC Medical Distributors

Marco Taglietti

Director/Board Member

Pharmaceuticals: Major

Eric J. Dadey

Corporate Officer/Principal

Pharmaceuticals: Major

Marco Taglietti

Chief Tech/Sci/R&D Officer

University of Pavia College/University

Marco Taglietti

Undergraduate Degree

Investment Managers

John Cochran

Private Equity Investor

Financial Conglomerates

Keith Kendall

President

HealthCare Institute of New Jersey

Marco Taglietti

Director/Board Member

Nycomed Salutar, Inc.

Eric J. Dadey

Corporate Officer/Principal

Medical Specialties

Marco Taglietti

Corporate Officer/Principal

Investment Managers

John Cochran

Douglas Bratton

Chief Operating Officer

Chief Executive Officer

Pharmaceuticals: Major

John McCracken

Corporate Officer/Principal

Reed & Carnrick Pharmaceuticals

A. Schobel

Corporate Officer/Principal

Pharmaceuticals: Major

Eric J. Dadey

Corporate Officer/Principal

Forest Research Institute, Inc.

Marco Taglietti

President

Pharmaceuticals: Major

Carl Kraus

Chief Tech/Sci/R&D Officer

Investment Managers

Douglas Bratton

Chief Executive Officer

Investment Managers

John Cochran

Douglas Bratton

Chief Executive Officer

President

Washington University School of Medicine College/University

Carl Kraus

Undergraduate Degree

Biotechnology

Marco Taglietti

Director/Board Member

BIODEXA PHARMACEUTICALS PLC Pharmaceuticals: Major

Keith Kendall

Director/Board Member

NCR Credit Corp.

Keith Kendall

President

Biotechnology

Carl Kraus

Chief Executive Officer

Investment Managers

John Cochran

Douglas Bratton

Director/Board Member

Chairman

Packaged Software

A. Schobel

Director/Board Member

Insurance Brokers/Services

John Cochran

Douglas Bratton

Chief Operating Officer

Director/Board Member

ACERAGEN, INC. Biotechnology

Carl Kraus

Chief Tech/Sci/R&D Officer

Statistiques

Internationale

Etats-Unis 45
Royaume-Uni 4
Canada 3
Italie 2

Sectorielle

Health Technology 24
Consumer Services 10
Finance 8
Commercial Services 4
Electronic Technology 2

Opérationnelle

Director/Board Member 84
Corporate Officer/Principal 57
Director of Finance/CFO 32
Undergraduate Degree 24
Independent Dir/Board Member 24
  1. Bourse
  2. Insiders
  3. Daniel Barber
  4. Connexions Sociétés